Kamakura, Japan

Hideki Kosono


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideki Kosono

Introduction

Hideki Kosono is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on acylsulfonamide derivatives. His research focuses on developing compounds that can provide effective treatments for various health conditions.

Latest Patents

One of Kosono's key patents is for acylsulfonamide derivatives, which include compounds such as 4-(3-trifluoromethyl)phenylethynyl-N-(2-(5-ketohexanoylamino)sulfonylphenyl)benzamide and 4-(3-trifluoromethyl)phenylethynyl-N-(2-(2-propyloxyacetylamino)sulfonylphenyl)benzamide. These derivatives exhibit a hypoglycemic effect that is equal to or superior to conventional hypoglycemic agents, while also being free from the side effects commonly associated with glitazone compounds. Kosono holds 1 patent for this innovative work.

Career Highlights

Kosono is affiliated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to explore and develop new therapeutic agents that can improve patient outcomes. His dedication to research and innovation has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Kosono has collaborated with esteemed colleagues such as Hiroshi Ikawa and Masato Nishimura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Hideki Kosono's contributions to the field of pharmaceuticals through his innovative acylsulfonamide derivatives highlight his commitment to improving health outcomes. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…